Incyte Biosciences Denmark ApS: Financial statements 2018
CVR: 35818790
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Incyte Biosciences Denmark ApS (CVR 35818790) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 3,030,527 and a net result of DKK 87,321 compared with DKK 46,870 the year before. That is an increase of 48.3% compared with the year before. Equity in the 2018 report amounted to DKK 241,323. The solvency ratio was 18.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,030,527
- Profit/Loss
- DKK 87,321
- Equity
- DKK 241,323
- Total Assets
- DKK 1,306,840
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 3M | 87K | 241K | 2 |
| 2017 | - | 2M | 47K | 154K | 1 |
| 2016 | - | 1.5M | 25K | 107K | - |
| 2015 | - | 1.5M | 26K | 82K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Incyte Biosciences Denmark ApS has published its annual report for 2017. Gross profit came to DKK 2,043,465, and the net result was DKK 46,870.
About Incyte Biosciences Denmark ApS
Incyte Biosciences Denmark ApS is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ARIAD PHARMACEUTICALS (DENMARK) ApS. The management consists of Ebba Cecilia Bröms. The board consists of Lee Jason Heeson (chair) and Ebba Cecilia Bröms. The company is owned by Incyte Biosciences International Sàrl. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 6,696,586 and a net result of DKK 361,151 compared with DKK 368,873 the year before. Equity in the 2025 report amounted to DKK 2,328,496.